MedTrace Logo

An Observational Study of Radial Access Embolization Procedures Using HydroPearl Microspheres

NCT04272216 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 99

Last updated 2025-09-09

Study results available
· View outcomes & findings →

Summary

This registry study is designed to collect data on the procedural success and complication rates in real-world patients undergoing HydroPearl embolization procedures via radial access.

Conditions

  • Uterine Fibroid
  • Arteriovenous Malformations
  • Hypervascular Tumors
  • Benign Prostatic Hyperplasia

Interventions

DEVICE

Treatment with HydroPearl via radial access

This is an observational study collecting data on patients who are already being treated with HydroPearl on-label per standard of care.

Sponsors & Collaborators

  • Terumo Medical Corporation

    lead INDUSTRY

Principal Investigators

  • Marcelo Guimaraes, MD · Medical University of South Carolina

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-02-06
Primary Completion
2022-03-07
Completion
2023-03-11
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04272216 on ClinicalTrials.gov